BEAM   $26.02  2.00% Market Closed After Close 25.95 -0.27%

Beam Therapeutics Inc
Total Cash 1.01B
totalCashPerShare 12.752
EBITDA -162.88M
Total Debt 165.24M
quickRatio 5.685
currentRatio 5.805
Total Revenue 352.57M
debtToEquity 19.346
Revenue/Share 4.353
ROA -0.08816
ROE -0.17171
grossProfits
freeCashflow -32.24M
operatingCashflow -137.47M
earningsGrowth
revenueGrowth -0.415
grossMargins -0.16853
ebitdaMargins -0.46198002
operatingMargins -8.91055
profitMargins -0.40563
enterpriseValue 1.24B
forwardPE -4.6415772
floatShares 64.45M
sharesOutstanding 82.42M
sharesShort 11.08M
sharesShortPriorMonth 11.62M
dateShortInterest
sharesPercentSharesOut 0.13%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.94%
Short Ratio help_outline 13.40%
shortPercentOfFloat 0.18%
impliedSharesOutstanding
bookValue 10.808
Price To Book help_outline 2.40
earningsQuarterlyGrowth
netIncomeToCommon -143.01M
trailingEps -1.62%
forwardEps -5.58%
enterpriseToEbitda -7.59
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.16 3Q 2024
institutionsCount 323
lastUpdated Sept. 16, 2024, 7:49 p.m.